In an integrated analysis of ACE2 and TMPRSS2 gene expression across clinical, genetic, and microbiome domains, Bao et al. found that cancer tissues broadly have a lower expression of ACE2 and TMPRSS2, though the cancers of the digestive tract do have the highest relative level [104]. This evidence concerns the gene ACE2 and cancer.